title: Expression of an LDL receptor allele with two different mutations (E256K and I402T).
abstract: OBJECTIVE
  To investigate the disease causing event in patients with familial hypercholesterolaemia, carrying two mutations each, E256K in exon 6 and I402T in exon 9, of the gene encoding the low density lipoprotein (LDL) receptor. It was not known whether the mutations were positioned in cis or trans, or if they were each pathogenic separately or only when present together.
  
  
  METHODS
  Polymerase chain reaction, denaturing gradient gel electrophoresis and sequencing were used to characterise the LDL receptor locus of the patients and family members. The different LDL receptor mutants, constructed in vitro by oligonucleotide directed mutagenesis, were expressed in LDL receptor deficient Chinese hamster ovary (CHO1d1A7) cells, to determine the effects of the mutations on LDL receptor function.
  
  
  RESULTS
  The two mutations were located on the same allele of the LDL receptor gene. All mutant constructs resulted in the production of a detectable protein in CHO cells. The cells expressing only the I402T mutation, or the combination of I402T and E256K mutations, were seriously affected in mediating uptake and degradation of LDL. Contrary to initial predictions, the cells expressing only the E256K mutation showed essentially the same binding, uptake, and degradation of 125I labelled LDL as cells transfected with normal LDL receptor cDNA. These results suggest that the pathogenic mutation in the patients heterozygous for the E256K/I402T allele is the I402T mutation, and that E256K alone is a rare sequence variation, which does not affect LDL receptor protein function. E256K was not detected either in DNA from a healthy population or in DNA from other hypercholesterolaemic patients studied.
  
  
  CONCLUSIONS
  Despite the information available on the structure-function relations between the LDL receptor and LDL receptor like proteins, predictions about the disease causing potential of a mutation are not reliable. These results suggest that the I402T mutation is pathogenic and that the substitution of E256K alone is a rare sequence variation, without a detectable phenotype modulating effect.
authors.affiliation: Department of Clinical Chemistry, University Hospital, Lund, Sweden. ulf.ekstrom@klinkem.lu.se
authors.forename: U
authors.initials: U
authors.lastname: Ekström
authors.forename: M
authors.initials: M
authors.lastname: Abrahamson
authors.forename: T
authors.initials: T
authors.lastname: Sveger
authors.forename: X M
authors.initials: XM
authors.lastname: Sun
authors.forename: A K
authors.initials: AK
authors.lastname: Soutar
authors.forename: P
authors.initials: P
authors.lastname: Nilsson-Ehle
mesh_terms: D000483:Alleles; D000818:Animals; D006224:Cricetinae; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000235:genetics*; D008297:Male; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D016133:Polymerase Chain Reaction; D011973:Receptors, LDL / Q000235:genetics*; D017422:Sequence Analysis, DNA
chemical_list: D011973:Receptors, LDL